Clinical activity of ipilimumab for metastatic uveal melanoma

Experience in daily practice with ipilimumab for the treatment of patients with metastatic melanoma: an early increase in lymphocyte and eosinophil counts is associated with improved survival

(2013) J. Delyon et al.   ANNALS OF ONCOLOGY

Activity of the oral MEK inhibitor trametinib in patients with advanced melanoma: a phase 1 dose-escalation trial

(2012) Gerald S Falchook et al.   LANCET ONCOLOGY

Ipilimumab activity in advanced uveal melanoma

(2012) Muhammad Adnan Khattak et al.   MELANOMA RESEARCH

Phase II Trial of Sorafenib in Combination with Carboplatin and Paclitaxel in Patients with Metastatic Uveal Melanoma: SWOG S0512

(2012) Shailender Bhatia et al.   PLoS One

Ipilimumab in pretreated patients with metastatic uveal melanoma: safety and clinical efficacy

(2011) Riccardo Danielli et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Aflibercept (VEGF Trap) in Inoperable Stage III or Stage IV Melanoma of Cutaneous or Uveal Origin

(2011) A. A. Tarhini et al.   CLINICAL CANCER RESEARCH

Anti-CTLA4 monoclonal antibodies: the past and the future in clinical application

(2011) Paolo A Ascierto et al.   Journal of Translational Medicine

Single-institution experience with ipilimumab in advanced melanoma patients in the compassionate use setting

(2010) Geoffrey Y. Ku et al.   CANCER

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

(2010) F. Stephen Hodi et al.   NEW ENGLAND JOURNAL OF MEDICINE

Oncogenic GNAQ mutations are not correlated with disease-free survival in uveal melanoma

(2009) J Bauer et al.   BRITISH JOURNAL OF CANCER

A Randomized, Double-Blind, Placebo-Controlled, Phase II Study Comparing the Tolerability and Efficacy of Ipilimumab Administered with or without Prophylactic Budesonide in Patients with Unresectable Stage III or IV Melanoma

(2009) J. Weber et al.   CLINICAL CANCER RESEARCH

Guidelines for the Evaluation of Immune Therapy Activity in Solid Tumors: Immune-Related Response Criteria

(2009) J. D. Wolchok et al.   CLINICAL CANCER RESEARCH

Ipilimumab monotherapy in patients with pretreated advanced melanoma: a randomised, double-blind, multicentre, phase 2, dose-ranging study

(2009) Jedd D Wolchok et al.   LANCET ONCOLOGY

Systemic Therapy for Unresectable Metastatic Melanoma: Impact of Biochemotherapy on Long-Term Survival

(2008) Agop Y. Bedikian et al.   Journal of Immunotoxicology

Frequent somatic mutations of GNAQ in uveal melanoma and blue naevi

(2008) Catherine D. Van Raamsdonk et al.   NATURE